Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02593864 · ClinicalTrials.gov registry record · NA

A Biomarker Stress Test for Detection of Early Osteoarthritis

A NA study, sponsored by VA Palo Alto Health Care System.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT02593864: Completed NA study, sponsored by VA Palo Alto Health Care System.

NCT02593864 is a NA study that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02593864, a NA study, has completed, sponsored by VA Palo Alto Health Care System.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Veterans have much higher risk of osteoarthritis (OA) then the general population. Knee OA is common among Veterans and is a leading cause of disability. The earliest stages of OA development, where the joint cartilage wears away, is usually painless. By the time Veterans experience symptoms, the OA is typically advanced and there is nothing that can be done except palliation until the joint is replaced with metal and plastic. If there was a blood test to provide early warning of cartilage wear and joint deterioration, Veterans could potentially be treated early enough to slow down or even prevent OA. So far, development of such a blood test has proved elusive. The investigators propose a new method to amplify the signs of cartilage wear in the blood by challenging the affected joint with a walking task. Similar to a cardiac stress test, this walking challenge may help to separate joints at risk from healthy joints. The investigators will also see if this 'OA stress test' can show if a simple and inexpensive load-modifying shoe can improve joint health in Veterans with early knee OA.

Primary Outcome

Knee adduction moment describes the medial/lateral load distribution of the knee measured while walking in a gait laboratory. Before normalization to account for size, the knee adduction moment is expressed in Nm. However, to account for different sized people, the knee adduction moment is transformed and expressed in percentage of body weight times height (%BW\*ht). Higher knee adduction moments have been linked to more severe osteoarthritis (OA). Knee adduction moment will be analyzed at basel

Interventions

  • DEVICE Variable-Stiffness Shoe

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2016-02
Est. Completion 2018-07
Phase NA
VA Palo Alto Health Care System

34 total trials

What the finished NCT02593864 record still lists

NCT02593864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Variable-Stiffness Shoe is the first listed.

NCT02593864 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02593864 about?

NCT02593864 is a clinical study titled "A Biomarker Stress Test for Detection of Early Osteoarthritis". Veterans have much higher risk of osteoarthritis (OA) then the general population. Knee OA is common among Veterans and is a leading cause of disability. The earliest stages of OA development, where the joint cartilage wears away, is usually painless. By the time Veterans experience symptoms, the OA...

What is the current status of trial NCT02593864?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-02. Estimated completion is 2018-07.

What interventions are being tested in trial NCT02593864?

The interventions under investigation include: Variable-Stiffness Shoe (DEVICE).

Who is sponsoring clinical trial NCT02593864?

This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02593864's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02593864, the US trial registry maintained by the National Library of Medicine. NCT02593864 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.